Trade Groups, Emord Rip FTC Interpretation Of POM Wonderful Ads
This article was originally published in The Tan Sheet
Executive Summary
An amici curiae brief filed in the POM Wonderful case by CHPA and CRN criticizes FTC for relying “on its own ‘expertise’ to determine the meaning of ambiguous advertisements.” A separate brief by attorney Jonathan Emord says FTC is creating unreasonable barriers for food product research.
You may also be interested in...
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
The nearly three-year battle between FTC and POM Wonderful moves to a federal appeals court, where the pomegranate juice and supplement firm asks the judges to nix the commission’s order that POM conduct two randomized controlled trials to support disease-related health claims.
POM Wonderful Misses Mark In Suit On FTC Claims Standard, Attorneys Say
A complaint challenging Federal Trade Commission claim substantiation requirements could backfire and strengthen the agency's rulemaking authorities, a food and drug attorney says
FTC's Pending Claim Substantiation Changes Will Weigh On Small Firms
The Federal Trade Commission soon will demand greater substantiation for dietary supplement health claims as the agency aligns its standards for clinical evidence more closely with FDA's